jerald radich
机构: fred hutchinson cancer research center
每年引用次数
引用次数
引用: 63,059
H-指数: 109
I10-指数 : 306
出版物: 787
A pilot study evaluating the safety and efficacy of imatinib given early after transplant for high-risk Philadelphia chromosome-positive leukemias
P.A. Carpenter , D.S. Snyder , M.E. Flowers , J.E. Sanders
Biology of Blood and Marrow Transplantation 12 ( 2) 86 -87
2006
Involvement of Fanconi Anemia (FA) Genes FANCG and FANCA in Human DNA Replication, Mitosis and Chromosome Segregation: A Gene Expression Profiling Study.
Ph. Guardiola , P. Ladne , J. Soulier , F. Siclon
Blood 104 ( 11) 2836 -2836
2004
PF409 DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER STOPPING FRONTLINE (1L) NILOTINIB: ENESTFREEDOM 192-WK RESULTS
D.M. Ross , T. Masszi , M.T. Gómez Casares , A. Hellmann
HemaSphere 3 157
1
2019
IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
Damien Reynaud , Eric Pietras , Keegan Barry-Holson , Alain Mir
Cancer Cell 20 ( 5) 661 -673
317
2011
Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
F. R. Appelbaum , F. R. Appelbaum , J. P. Radich , D. Head
Leukemia 8 ( 12) 2118 -2126
49
1994
Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies
F. R. Appelbaum , F. R. Appelbaum , J. P. Radich , D. Head
Leukemia 10 ( 12) 1901 -1910
29
1996
Clinical implications of FLT3 mutations in pediatric AML
S. Meshinchi , T. A. Alonzo , D. L. Stirewalt , M. Zwaan
Blood 108 ( 12) 3654 -3661
437
2006
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia
J. A. Pollard , T. A. Alonzo , R. B. Gerbing , W. G. Woods
Blood 108 ( 8) 2764 -2769
56
2006
Chronic myeloid leukemia: reminiscences and dreams
T. I. Mughal , J. P. Radich , M. W. Deininger , J. F. Apperley
Haematologica 101 ( 5) 541 -558
121
2016
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A. Hochhaus , M. Baccarani , R. T. Silver , C. Schiffer
Leukemia 34 ( 4) 966 -984
809
2020
Microfluidics for single-cell genetic analysis
A. M. Thompson , A. L. Paguirigan , J. E. Kreutz , J. P. Radich
Lab on a Chip 14 ( 17) 3135 -3142
48
2014
Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data
K. Y. Yeung , T. A. Gooley , A. Zhang , A. E. Raftery
Bioinformatics 28 ( 6) 823 -830
11
2012
N-ras Mutations in Acute Myelogenous Leukemia: A Review of the Current Literature and an update of the Southwest Oncology Group Experience
J. P. Radich , K. J. Kopecky , F. Appelbaum , C. L. Willman
Leukemia & Lymphoma 6 325 -334
19
1992
The detection and significance of minimal residual disease in acute and chronic leukemia.
N.-G. Chung , V. Buxhofer-Ausch , J. P. Radich
Tissue Antigens 68 ( 5) 371 -385
17
2006
Gene expression changes associated with progression and response in chronic myeloid leukemia
J. P. Radich , H. Dai , M. Mao , V. Oehler
Proceedings of the National Academy of Sciences of the United States of America 103 ( 8) 2794 -2799
474
2006
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
A. G. Chapuis , G. B. Ragnarsson , H. N. Nguyen , C. N. Chaney
Science Translational Medicine 5 ( 174)
234
2013
Expression of topoisomerase (topo) II in adult acute myeloid leukemia (AML): Relationships to immunophenotype and treatment outcomes.
A. P. Michelson , K. J. Kopecky , E. R. Koegle , J. E. Anderson
Journal of Clinical Oncology 29 6564 -6564
2011
Association of early molecular response to nilotinib with probability of cytogenetic response in chronic myeloid leukemia patients (pts) who fail imatinib.
S. Branford , G. Martinelli , G. Saglio , D. Kim
Journal of Clinical Oncology 28 ( 15_suppl) 6513 -6513
3
2010
Detection of new mutations in patients (pts) with imatinib-resistant chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib.
A. Hochhaus , G. Saglio , H. Kantarjian , A. Haque
Journal of Clinical Oncology 28 ( 15_suppl) 6516 -6516
2010
BCR-ABL transcript analysis of patients (pts) with imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib.
D. Kim , G. Saglio , G. Martinelli , Y. Shou
Journal of Clinical Oncology 28 ( 15_suppl) 6567 -6567
2010